A solid phase immunofluorometric assay for anti-lymphocyte antibodies

Area of Science:

• Immunology
• Biochemistry
• Assay Development

Background:

• Detection of anti-lymphocyte antibodies is crucial for various clinical applications, including transplantation and monitoring pregnancy.
• Existing methods like microlymphocytotoxicity and indirect immunofluorescence have limitations in sensitivity and scope.

Purpose of the Study:

• To develop a novel, highly sensitive solid-phase immunofluorometric assay for detecting anti-lymphocyte antibodies.
• To optimize assay conditions and evaluate the stability and performance of the developed assay.

Main Methods:

• Development of a solid-phase assay using agarose beads conjugated with partially purified HLA antigens.
• Optimization of assay parameters including bead concentration, serum concentration, FTC-conjugate concentration, and incubation times.
• Comparison of the assay's sensitivity against microlymphocytotoxicity and indirect immunofluorescence tests.

Main Results:

• The developed assay detected both complement-fixing and non-complement-fixing antibodies.
• It demonstrated approximately 20-fold higher sensitivity compared to microlymphocytotoxicity and indirect immunofluorescence tests.
• HLA antigen-bound beads showed stability for at least 54 days at 5°C or -80°C, retaining 80% activity after lyophilization.
• Pregnancy sera showed significantly higher fluorescence intensity than normal sera.

Conclusions:

• The solid-phase immunofluorometric assay is a sensitive and stable method for detecting anti-lymphocyte antibodies.
• This assay offers a significant improvement over existing techniques for antibody detection.
• The assay's high sensitivity and stability make it suitable for clinical and research applications, including the detection of lymphocytotoxic antibodies in pregnancy sera.